Aizzel Trieu
Nurse Practitioner · Riverside, CANPI 1689214074
Payments from drug & device makers
Across 668 payments — averaging $20.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Alkermes, Inc.$2K
- Teva Pharmaceuticals USA, Inc.$2K
- Vanda Pharmaceuticals Inc.$1K
- Otsuka America Pharmaceutical, Inc.$1K
- AbbVie$1K
- plus $4K from 16 others
What the payments were for
- Food & beverage$13,61599%
- Education$2031%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 94 | $2,073 |
| Alkermes, Inc. | 83 | $2,013 |
| Teva Pharmaceuticals USA, Inc. | 84 | $1,671 |
| Vanda Pharmaceuticals Inc. | 58 | $1,406 |
| Otsuka America Pharmaceutical, Inc. | 48 | $1,157 |
| AbbVie | 72 | $1,150 |
| Lundbeck LLC | 71 | $1,124 |
| Sunovion Pharmaceuticals Inc. | 63 | $914 |
| Neurocrine Biosciences, Inc. | 26 | $695 |
| Axsome Therapeutics, Inc. | 24 | $601 |
| E.r. Squibb & Sons, L.L.C. | 9 | $329 |
| Johnson & Johnson | 11 | $233 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $194 |
| Idorsia Pharmaceuticals US Inc | 3 | $58 |
| Supernus Pharmaceuticals, Inc. | 3 | $50 |
| Bausch Health US, LLC | 2 | $37 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Jazz Pharmaceuticals Inc. | 1 | $22 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $19 |
| Corium, LLC | 1 | $19 |
| Luye Pharma (USA) Ltd. | 1 | $14 |
| Adlon Therapeutics L.p. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,818 in reported general payments places this provider in the 95th percentile of 6,779 nurse practitioner providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bupropion XlBupropion Hcl | 33 | $1,570 |
| Trazodone Hcl | 48 | $1,290 |
| Aripiprazole | 37 | $1,109 |
| Hydroxyzine Hcl | 74 | $828 |
| Lurasidone Hcl | 40 | $616 |
| Risperidone | 41 | $424 |
| Hydroxyzine Pamoate | 23 | $397 |
| Oxcarbazepine | 17 | $284 |
| Prazosin Hcl | 37 | $281 |
| Quetiapine Fumarate | 40 | $187 |
| Divalproex Sodium ErDivalproex Sodium | 16 | $165 |
| Escitalopram Oxalate | 26 | $90 |
| Mirtazapine | 12 | $79 |
| Gabapentin | 20 | $78 |
| Zolpidem Tartrate | 22 | $57 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Riverside
- Rhonda HewittStanford$917K
- Linda TrinhIrvine$899K
- Denise SinagaNorthridge$728K
- Debbie TaySanta Monica$642K
- Joe GorelickCampbell$638K
- Lynsey LakinArcadia$540K
- Kelly ChoiRancho Cucamonga$483K
- Hamta ZareStanford$428K
- Shawna ChrismanRoseville$425K
- Angelina CollinsSan Diego$356K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.